Health Condition 1: G379- Demyelinating disease of central nervous system, unspecified
Conditions
Interventions
Intervention1: nil: nil
Sponsors
DR Mathakala Aparna
Eligibility
Inclusion criteria
Inclusion criteria: 1.Confirmed Diagnosis: Patients with a confirmed diagnosis of GBS based on clinical criteria, electrophysiological studies, and cerebrospinal fluid analysis. 2. Age Range: Include patients of age above 18 years 3. Patients presenting with Acute flaccid Paralysis with 28 days of illness. 4. Consent: Patients or their guardians must provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with features of Hypokalemic periodic paralysis. 2. Patients with features of upper motor neuron signs and symptoms. 3. Patients admitted with history of exposure to toxins. 4. Patients with severe terminal illness. 5. Patients in whom the weakness progressed for more than 4 weeks. 6. Patients age less than 18 years of age 7.Patients with a chronic form of GBS, such as chronic inflammatory demyelinating polyneuropathy (CIDP), to maintain focus on the acute presentation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognosis of the disease will be studied based on the power improvement in all limbs.Timepoint: at every 2 weeks for 6 months power will be assessed. | — |
Secondary
| Measure | Time frame |
|---|---|
| ICU requirement of the patient will be assessed for how many days.Timepoint: at 2 weeks, 4 weeks, 6 weeks. for every 2 weeks assesemenet will be done | — |
Countries
India
Contacts
Public ContactDR Mathakala Aparna
Jawaharlal Nehru Medical College
Outcome results
None listed